Fulgent Genetics to Announce Third Quarter 2019 Financial Results on Monday November 4, 2019
October 15 2019 - 7:00AM
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the
“company”) today announced that it will release its third quarter
2019 financial results after the market closes on Monday November
4, 2019. The company’s Chairman and Chief Executive Officer Ming
Hsieh and its Chief Financial Officer Paul Kim will host a
conference call for the investment community the same day at 4:30
PM ET (1:30 PM PT) to discuss the results and answer questions.
The call can be accessed through a live audio webcast in the
Investors section of the company’s website,
http://ir.fulgentgenetics.com, and through a live conference call
by dialing (855) 321-9535 using the conference ID 8069749. An audio
replay will be available in the Investors section of the company’s
website or by calling (855) 859-2056 using passcode 8069749 through
November 11, 2019.
About Fulgent Genetics
Fulgent Genetics is a technology company with a focus on
offering comprehensive genetic testing to provide physicians with
clinically actionable diagnostic information they can use to
improve the quality of patient care. The company has developed a
proprietary technology platform that allows it to offer a broad and
flexible test menu and continually expand and improve its
proprietary genetic reference library, while maintaining accessible
pricing, high accuracy and competitive turnaround times. The
company believes its test menu offers more genes for testing than
its competitors in today’s market, which enables it to provide
expansive options for test customization and clinically actionable
results.
Investor Relations Contacts:The Blueshirt
GroupNicole Borsje, 415-217-2633, nborsje@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Apr 2024 to May 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From May 2023 to May 2024